Anna Gawlik

Innovation in the field of predicting prostate cancer recurrence and metastasis has been made possible by Anna Gawlik, an inventor located in St. Charles, IL (US). Anna has a single patent to her name, titled "Predicting prostate cancer biochemical recurrence and metastasis with computer-extracted features from tumor nuclei and benign regions."

This patent focuses on a method to predict the likelihood of biochemical recurrence (BCR) or metastasis in prostate cancer patients. It involves accessing a series of images of cancerous tissue, including both tumor and tumor-adjacent benign regions. These images consist of different stain types. Anna's method entails segmenting the cellular nuclei in the images, extracting relevant features from the tumor and benign regions, generating a combined feature set, and inputting it into a machine learning classifier. The classifier then provides a probability of BCR or metastasis occurring in the tissue, allowing for the classification of the region as likely or unlikely to experience these outcomes.

Anna Gawlik works at Case Western Reserve University, a renowned institution in the field of medical research and education. She collaborates with colleagues such as Anant Madabhushi and George Lee, who are also involved in this innovative work.

This breakthrough patent from Anna Gawlik showcases her expertise in the field of medical imaging and predictive analytics. By enabling more accurate predictions, her invention holds significant potential in improving patient outcomes and guiding appropriate treatment plans for prostate cancer.